UBS Maintains a 'Buy' on Occidental Petroleum (OXY); Boosting Estimates After 2nd Straight Beat
OXY Hot Sheet
Rating Summary:9 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 7 | New: 26
UBS maintains a 'Buy' on Occidental Petroleum (NYSE: OXY) price target raised from $110 to $114.
UBS analyst says, "We are revising our 2012-13 EPS/CFPS to $7.95/$15.40 and $7.80/$15.45 from $8.35/$14.05 and $8.55/$14.50 on higher production and DD&A expenses, as well as lower current taxes. We forecast 2012-13 production growth of 6% per annum, in the middle of its targeted long term growth of 5-8% per annum."
For an analyst ratings summary and ratings history on Occidental Petroleum click here. For more ratings news on Occidental Petroleum click here.
Shares of Occidental Petroleum closed at $103.46 yesterday, with a 52 week range of $66.36-$115.93.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
UBS analyst says, "We are revising our 2012-13 EPS/CFPS to $7.95/$15.40 and $7.80/$15.45 from $8.35/$14.05 and $8.55/$14.50 on higher production and DD&A expenses, as well as lower current taxes. We forecast 2012-13 production growth of 6% per annum, in the middle of its targeted long term growth of 5-8% per annum."
For an analyst ratings summary and ratings history on Occidental Petroleum click here. For more ratings news on Occidental Petroleum click here.
Shares of Occidental Petroleum closed at $103.46 yesterday, with a 52 week range of $66.36-$115.93.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Needham & Company Reiterates a 'Buy' on NetApp (NTAP); Solid 4Q Overshadowed by Conservative 1Q
- Barclays Maintains an 'Equalweight' on J. C. Penney (JCP); Slashing PT on Disappointing Results
- Barclays Earnings Review on Analog Devices (ADI); Slow and Sure Wins The Race
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
